94.31
-0.22
(-0.23%)
At close: January 17 at 3:00:00 PM EST
Key Executives
Amounts are as of December 31, 2024 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.
Name | Title | Pay | Exercised | Year Born |
---|---|---|---|---|
Mr. Diggory William Howitt BE (Hons), MBA | CEO, MD, President & Executive Director | 2.7M | -- | 1967 |
Mr. Jan Janssen MSc Elec Eng | Chief Technology Officer | 1.22M | -- | 1965 |
Mr. Stuart Sayers | President of Asia Pacific & Latin America | 1.15M | -- | -- |
Sarah Thom | Chief Financial Officer | -- | -- | -- |
Ms. Karen O'Driscoll | Chief Information Officer | -- | -- | -- |
Ms. Kristina Devon | Vice President of Investor Relations | -- | -- | -- |
Mr. Rob McGrory | Group General Counsel & Company Secretary | -- | -- | -- |
Ms. Jennifer Stevenson | VP of Corporate Communications & Brand | -- | -- | -- |
Mr. Dean Phizacklea | Senior Vice President of Global Strategic Marketing | -- | -- | -- |
Ms. Jennifer Hornery | Senior Vice President of Global People & Culture | -- | -- | -- |
Cochlear Limited
1 University Avenue
Macquarie University
Sydney, NSW 2109
Australia
- Sector:
- Healthcare
- Industry: Medical Devices
- Full Time Employees:
- 4,996
Description
Cochlear Limited provides implantable hearing solutions for children and adults worldwide. It offers cochlear implant systems, sound processor upgrades, bone conduction systems, accessories, and other products. The company was founded in 1981 and is headquartered in Sydney, Australia.
Corporate Governance
Cochlear Limited’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.
Upcoming Events
February 13, 2025 at 9:30 PM UTC
Cochlear Limited Earnings Date
Recent Events
October 25, 2024 at 12:00 AM UTC
Dividend Date
September 18, 2024 at 12:00 AM UTC
Ex-Dividend Date
Related Tickers
CVRX CVRx, Inc.
17.62
+1.85%
INGN Inogen, Inc.
10.47
-0.48%
PEN Penumbra, Inc.
263.69
+0.53%
GKOS Glaukos Corporation
156.39
-0.08%
ESTA Establishment Labs Holdings Inc.
34.56
-0.23%
IRTC iRhythm Technologies, Inc.
108.33
+1.25%
INSP Inspire Medical Systems, Inc.
177.68
+2.21%
PACB Pacific Biosciences of California, Inc.
1.6400
+2.50%
ABT Abbott Laboratories
113.48
-0.38%
TMDX TransMedics Group, Inc.
57.20
-1.41%